The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
General Updates | The key challenges in treating multiple myeloma in Ireland
Denis O’Keeffe, MD, University Hospital Limerick, Limerick, Ireland, discusses current obstacles in the management of multiple myeloma, specifically focusing on the situation in Ireland. Dr O’Keeffe explains that despite the increasing number of treatment options for patients, there is restricted access to novel therapies depending on each country. In addition, financing options may also be restricted. Dr O’Keeffe also mentions the issue of managing relapsed/refractory (R/R) patients. This interview was recorded virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
